AAAAAA
Results:
1-19
|
Results: 19
Authors:
KHER A
ALDIERI R
HEMKER HC
BEGUIN S
Citation: A. Kher et al., LABORATORY ASSESSMENT OF ANTITHROMBOTIC THERAPY - WHAT TESTS AND IF SO WHY, Haemostasis, 27(5), 1997, pp. 211-218
Authors:
BOISSEL JP
PERRET L
BOUVENOT G
CASTAIGNE A
GERARDCOUE MJ
MAILLERE P
MISMETTI P
VRAY M
AVOUAC B
BEGAUD B
CAULIN C
CHARPAK Y
CHAUMETRIFFAUD P
COSTAGLIOLA D
DEGOS F
DESTORS JM
DOYON F
FAGNANI F
GIRI I
GIRRE JP
GOEHRS JM
KHER A
MOCCATTI D
MUNOZ A
DECURZON AP
PLETAN Y
ROY P
VASMANT D
WAJMAN A
Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285
Authors:
DHAWAN PS
SHAH S
ALVARES J
KHER A
SHANKARAN K
KANDOTH P
SHETH P
KAMATH H
KOPPIKAR G
GILL HH
KALRO RH
Citation: Ps. Dhawan et al., SEROPREVALENCE OF HEPATITIS-A VIRUS IN MUMBAI, INDIA AND, IMMUNOGENICITY AND REACTOGENICITY OF HEPATITIS-A VACCINE, Gastroenterology, 112(4), 1997, pp. 1256-1256
Authors:
TOULEMONDE F
KHER A
Citation: F. Toulemonde et A. Kher, OPTIMAL DURATION FOR PROPHYLAXIS OF DEEP-VEIN THROMBOSIS - THE NEW FOCUS, Clinical and applied thrombosis/hemostasis, 2(4), 1996, pp. 285-288
Authors:
SHAH AM
CHATTOPADHYAY A
KHER A
BHARUCHA BA
KARAPURKAR AP
Citation: Am. Shah et al., CRANIOSYNOSTOSIS WITH MARFAN-SYNDROME, HAND AND FOOT ANOMALIES, Clinical dysmorphology, 5(3), 1996, pp. 263-266
Authors:
LAURENT S
VANHOUTTE P
CAVERO I
CHABRIER PE
DUPUIS B
ELGHOZI JL
HAMON G
JANIAK P
JUILLET Y
KHER A
KOEN R
MADONNA O
MAFFRAND JP
PRUNEAU D
THUILLEZ C
Citation: S. Laurent et al., THE ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET, Fundamental and clinical pharmacology, 10(3), 1996, pp. 243-257
Authors:
FIESSINGER JN
LOPEZFERNANDEZ M
GATTERER E
GRANQVIST S
KHER A
OLSSON CG
SODERBERG K
Citation: Jn. Fiessinger et al., ONCE-DAILY SUBCUTANEOUS DALTEPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, FOR THE INITIAL TREATMENT OF ACUTE DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 76(2), 1996, pp. 195-199
Authors:
KHER A
SAMAMA MM
Citation: A. Kher et Mm. Samama, LOW-MOLECULAR-WEIGHT HEPARIN IN UNSTABLE ANGINA, Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1495-1500
Authors:
SAMAMA MM
KHER A
Citation: Mm. Samama et A. Kher, BIOLOGICAL MONITORING ON THE PREVENTION O F COMPLICATIONS OF ANTITHROMBOTIC AGENTS, Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1569-1577
Authors:
LAURENT S
VANHOUTTE P
CAVERO I
CHABRIER PE
DUPUIS B
ELGHOZI JL
HAMON G
JANIAK P
JUILLET Y
KHER A
KOEN R
MADONNA O
MAFFRAND JP
PRUNEAU D
THUILLEZ C
MOURAD JJ
Citation: S. Laurent et al., ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET, Therapie, 50(4), 1995, pp. 387-398
Authors:
TOULEMONDE F
KHER A
Citation: F. Toulemonde et A. Kher, MONITORING OF HEPARIN IN THE DEEP VENOUS THROMBOSIS TREATMENT - AN OBSOLETE QUESTION, Annales de cardiologie et d'angeiologie, 44(3), 1995, pp. 151-159
Authors:
KHER A
DECHAVANNE M
Citation: A. Kher et M. Dechavanne, LOW-MOLECULAR-WEIGHT HEPARINS IN TOTAL HI P-ARTHROPLASTY - THE YEAR 1994, Annales francaises d'anesthesie et de reanimation, 13(6), 1994, pp. 888-893
Authors:
ALHENCGELAS M
JESTINLEGUERNIC C
VITOUX JF
KHER A
AIACH M
FIESSINGER JN
Citation: M. Alhencgelas et al., ADJUSTED VERSUS FIXED DOSES OF THE LOW-MOLECULAR-WEIGHT HEPARIN FRAGMIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 71(6), 1994, pp. 698-702
Authors:
WAHLBERG TB
KHER A
Citation: Tb. Wahlberg et A. Kher, LOW-MOLECULAR-WEIGHT HEPARIN AS THROMBOPROPHYLAXIS IN PREGNANCY - A RETROSPECTIVE ANALYSIS FROM 14 EUROPEAN CLINICS, Haemostasis, 24(1), 1994, pp. 55-56
Authors:
TOULEMONDE F
KHER A
Citation: F. Toulemonde et A. Kher, HEPARINS AND TRANSAMINASES - AN ENIGMA WI THOUT IMPORTANCE IN 1994, Therapie, 49(4), 1994, pp. 356-358
Authors:
WAHLBERG T
OHLEN A
KHER A
Citation: T. Wahlberg et al., FRAGMIN (LMW-HEPARIN) AS THROMBO-PROPHYLAXIS IN PREGNANCY - A RETROSPECTIVE STUDY IN 201 PATIENTS ON SAFETY AND EFFICACY, Thrombosis and haemostasis, 69(6), 1993, pp. 712-712
Authors:
FRICKER JP
KHER A
VERGNES Y
HEITZ A
SCHACH R
RODIER JF
JANSER JC
Citation: Jp. Fricker et al., 10 DAYS OR 20 DAYS PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ONCOLOGICAL SURGERY BY A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN-R), Thrombosis and haemostasis, 69(6), 1993, pp. 1113-1113
Authors:
DERLON A
CHARRIERAS C
KHER A
LEQUERREC A
HOUTTEVILLE JP
DERLON JM
Citation: A. Derlon et al., SAFETY AND EFFICACY OF A LOW-MOLECULAR-WEIGHT HEPARIN, FRAGMIN(R) IN PATIENTS UNDERGOING NEUROSURGERY - A RANDOMIZED, PROSPECTIVE DOUBLE-BLIND PILOT-STUDY, Thrombosis and haemostasis, 69(6), 1993, pp. 1115-1115
Authors:
PALSULE C
GANGOPADHYAY S
KHER A
BORST W
SCHMIDT U
SCHEHR B
SCHRODER B
Citation: C. Palsule et al., FAST PHOTOLUMINESCENCE DECAY IN A-SIH, Physical review. B, Condensed matter, 47(15), 1993, pp. 9309-9318
Risultati:
1-19
|